Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Theravance Biopharma buy tamam

Start price
€19.21
22.08.19 / 50%
Target price
€36.00
04.11.21
Performance (%)
-60.69%
End price
€7.55
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €7.55. Massive losses of -60.69% were the result for the BUY prediction by tamam. tamam has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Theravance Biopharma 1.170% 1.170% -16.019% -46.605%
iShares Core DAX® -0.922% -1.078% 12.165% 16.796%
iShares Nasdaq 100 0.371% -0.556% 38.622% 49.370%
iShares Nikkei 225® 2.224% -2.825% 19.015% 4.643%
iShares S&P 500 -0.026% -0.788% 28.485% 42.479%

Comments by tamam for this prediction

In the thread Theravance Biopharma diskutieren
Prediction Buy
Perf. (%) -60.69%
Target price 26.000
Change
Ends at 04.11.21

Buy mit Kursziel 26,0

Prediction Buy
Perf. (%) -60.69%
Target price 36.000
Change
Ends at 04.11.21

Kursziel geändert auf 36,0

In the thread Trading Theravance Biopharma
Prediction Buy
Perf. (%) -60.69%
Target price 36.000
Change
Ends at 04.11.21

Die von tamam gewählte maximale Laufzeit wurde überschritten